Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice.

Transcriptional silencing of genes transferred into hematopoietic stem cells poses one of the most significant challenges to the success of gene therapy. If the transferred gene is not completely silenced, a progressive decline in gene expression as the mice age often is encountered. These phenomena were observed to various degrees in mouse transplant experiments using retroviral vectors containing a human beta-globin gene, even when cis-linked to locus control region derivatives. Here, we have investigated whether ex vivo preselection of retrovirally transduced stem cells on the basis of expression of the green fluorescent protein driven by the CpG island phosphoglycerate kinase promoter can ensure subsequent long-term expression of a cis-linked beta-globin gene in the erythroid lineage of transplanted mice. We observed that 100% of mice (n = 7) engrafted with preselected cells concurrently expressed human beta-globin and the green fluorescent protein in 20-95% of their RBC for up to 9.5 mo posttransplantation, the longest time point assessed. This expression pattern was successfully transferred to secondary transplant recipients. In the presence of beta-locus control region hypersensitive site 2 alone, human beta-globin mRNA expression levels ranged from 0.15% to 20% with human beta-globin chains detected by HPLC. Neither the proportion of positive blood cells nor the average expression levels declined with time in transplanted recipients. Although suboptimal expression levels and heterocellular position effects persisted, in vivo stem cell gene silencing and age-dependent extinction of expression were avoided. These findings support the further investigation of this type of vector for the gene therapy of human hemoglobinopathies.

[1]  J. T. Kadonaga,et al.  The “Dark Side” of Chromatin Remodeling Repressive Effects on Transcription , 1999, Cell.

[2]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[3]  S. Elgin,et al.  Putting Boundaries on Silence , 1999, Cell.

[4]  M. Mathews-Roth,et al.  Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy , 1999, Nature Medicine.

[5]  Cameron S. Osborne,et al.  Amelioration of Retroviral Vector Silencing in Locus Control Region β-Globin-Transgenic Mice and Transduced F9 Embryonic Cells , 1999, Journal of Virology.

[6]  F. Grosveld.  Activation by locus control regions? , 1999, Current opinion in genetics & development.

[7]  S. Rivella,et al.  Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. , 1998, Seminars in hematology.

[8]  H. Raftopoulos,et al.  Long-Term Transfer and Expression of the Human β-Globin Gene in a Mouse Transplant Model , 1997 .

[9]  C. Eaves,et al.  Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. , 1997, Human gene therapy.

[10]  J. Dong,et al.  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Grosveld,et al.  Evaluation of β-globin gene therapy constructs in single-copy transgenic mice. , 1997 .

[12]  T. Yen,et al.  Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts , 1995, Molecular and cellular biology.

[13]  P. Lansdorp,et al.  Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. , 1994, Blood.

[14]  D. Tuan,et al.  Mutagenesis of retroviral vectors transducing human beta‐globin gene and beta‐globin locus control region derivatives results in stable transmission of an active transcriptional structure. , 1994, The EMBO journal.

[15]  T. Hawley,et al.  Versatile retroviral vectors for potential use in gene therapy. , 1994, Gene therapy.

[16]  R. Nagel,et al.  High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Razin,et al.  Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. , 1992, Genes & development.

[18]  N. Proudfoot,et al.  Definition of an efficient synthetic poly(A) site. , 1989, Genes & development.

[19]  D. Tuan,et al.  An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Goff,et al.  Construction and use of a safe and efficient amphotropic packaging cell line. , 1988, Virology.

[21]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[22]  G. Kollias,et al.  Position-independent, high-level expression of the human β-globin gene in transgenic mice , 1987, Cell.

[23]  D. Tuan,et al.  The "beta-like-globin" gene domain in human erythroid cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.